1. Advanced Glycation End-Products Enhance Lung Cancer Cell Invasion and Migration
   Te-Chun Hsia et al, 2016, IJMS CrossRef
2. Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer
   Ting Zhou et al, 2015, Sci Rep CrossRef
3. Oxidation, glycation and glycoxidation—The vicious cycle and lung cancer
   Saheem Ahmad et al, 2017, Seminars in Cancer Biology CrossRef
4. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients
   Yoshikane Yamauchi et al, 2017, Lung Cancer CrossRef
5. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis
   Sonia Blanco-Prieto et al, 2017, BMC Cancer CrossRef
6. The ectoenzyme-side of matrix metalloproteinases (MMPs) makes inflammation by serum amyloid A (SAA) and chemokines go round
   Mieke De Buck et al, 2018, Immunology Letters CrossRef
7. Association between serum amyloid A levels and cancers: a systematic review and meta-analysis
   Jielin Zhou et al, 2018, Postgrad Med J CrossRef
8. Differential diagnosis of lung cancer, its metastasis and chronic obstructive pulmonary disease based on serum Vegf, Il-8 and MMP-9
   Murali M. S. Balla et al, 2016, Sci Rep CrossRef
9. Soluble sPD-L1 and serum amyloid A1 as potential biomarkers for lung cancer
   Dragana Jovanović et al, 2019 CrossRef
10. CRP evaluation in non-small cell lung cancer
    Hassan Aref et al, 2014, Egyptian Journal of Chest Diseases and Tuberculosis CrossRef
11. Diagnostic value of suPAR in differentiating noncardiac pleural effusions from cardiac pleural effusions
    Savas Ozsu et al, 2016, The Clinical Respiratory Journal CrossRef
12. Host Cytokine Responses Induced after Overnight Stimulation with Novel M. tuberculosis Infection Phase-Dependent Antigens Show Promise as Diagnostic Candidates for TB Disease
    Paulin N. Essone et al, 2014, PLoS ONE CrossRef
13. Proteomics biomarkers for non-small cell lung cancer.
    Joanna Kisluk et al, 2014, J Pharm Biomed Anal CrossRef
14. Identification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study
    Halmurat Upur et al, 2015, BMC Complement Altern Med CrossRef
15. Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium
    Charles E. Birse et al, 2015, Clin Proteom CrossRef
16. null
    Hoseok I et al, 2015 CrossRef
17. A review of canakinumab and its therapeutic potential for non-small cell lung cancer
    Kara M. Schenk et al, 2019, Anti-Cancer Drugs CrossRef
18. Increased serum amyloid A as potential diagnostic marker for lung cancer: a meta-analysis based on nine studies.
    Rong Biaoxue et al, 2016, BMC Cancer CrossRef
19. Study on the correlation of serum amyloid A level with overall survival and radiation pneumonitis in non-small cell lung cancer patients receiving thoracic radiotherapy
    Jing Zhao et al, 2017, Prec. Radiat. Oncol. CrossRef
20. Serum amyloid A: A potential biomarker of lung disorders
    Lucia Vietri et al, 2019, Respiratory Investigation CrossRef
21. Advanced glycation end products (AGEs), protein aggregation and their cross talk: new insight in tumorigenesis
    Ejazul Haque et al, 2019 CrossRef
22. A Strong Decrease in TIMP3 Expression Mediated by the Presence of miR-17 and 20a Enables Extracellular Matrix Remodeling in the NSCLC Lesion Surroundings
    Karolina H. Czarnecka et al, 2019, Front. Oncol. CrossRef
23. The Role of Interleukin 1β in the Pathogenesis of Lung Cancer
    Edward B. Garon et al, 2020, JTO Clinical and Research Reports CrossRef
24. Molecular approaches to lung cancer prevention
    Asrar Alam et al, 2021, Future Oncology CrossRef
25. Baseline and Early Changes in Circulating Serum Amyloid A (SAA) Predict Survival Outcomes in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti-PD-1/PD-L1 Monotherapy
    Li-Na He et al, 2021, Lung Cancer CrossRef
26. New Insights on Old Biomarkers Involved in Tumor Microenvironment Changes and Their Diagnostic Relevance in Non-Small Cell Lung Carcinoma
    Katarzyna Wadowska et al, 2021, Biomolecules CrossRef
27. Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibition
    Jay M Lee et al, 2022, Future Oncology CrossRef
28. Matrix Metalloproteinases and Stress Hormones in Lung Cancer Progression
    Georgina Gonzalez-Avila et al, 2022, Journal of Oncology CrossRef
29. Discovery of protein biomarkers for venous thromboembolism in non-small cell lung cancer patients through data-independent acquisition mass spectrometry
    Yanhong Liu et al, 2023, Front. Oncol. CrossRef
30. Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management
    Dani Ran Castillo et al, 2023, IJMS CrossRef